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Abstract 
Nowadays diabetes is the most dreadful disease for humankind in the whole world. Indians are more centrally 
obese at a given level of BMI compared to white Caucasians and that Indians are more insulin resistant even 
at lower level of BMI so they are more prone to have diabetes.. Consumption of fenu greek seed decreases the 
blood glucose level as its amount is inversely associated with insulin resistance. A detailed clinical 
examination done on selected patients. The criteria for the selection are as follows: 1.All patients are 
sedentary middle aged workers. 2. Patients with complications like were not included 3.Patients selected 
were explained the outline and aim of the study. They were advised to have fenugreek seed  in the form of 
powder. 4. We made 3 groups. Group A fed 5 gm, group B fed 10 gm and group C fed 15 gm of fenugreek 
seed . 5.Patients are recalled after 2 weeks for the investigation to know the proper effect of fenugreek seed. 
6.The investigations include Anthropometric data, GTT, blood glucose, and serum lipid profile. The test 
applied for clinical estimation of blood glucose is GOD-POD (glucose oxidase peroxiadse) method. This 
study proves that consumption of fenugreek seed improves the blood glucose levels in the diabetics’ patients 
Keywords: diabetes, fenugreek seed, polysaccharide etc. 
1. Introduction: Diabetes Mellitus is a chronic disease that has affected humankind throughout the world. 
The life span of diabetics is shorter than that of non diabetics at nearly all ages. Diabetes has been defined as 
a genetically and clinically heterogeneous group of disorder all of which show glucose intolerance.1.4, 5, 11 
Prevelance- Diabetes is on increase in India. The multicenter ICMR study showed a prevalence of 2.5 % in 
the urban and 1.8% in the rural population above the age of 15 years. One in every eight individuals in India 
is a Diabetic. There are 171 million people worldwide suffering from diabetes in 2000 according to World 
Health Organization (WHO) statistics and this number would be more than double by 2030 (WHO 2008). 
The disease is responsible for 3.2 million deaths every year (WHO 2008). 
• Diabetes mellitus is characterized by high blood glucose level with typical manifestations of thirst, 
polyuria, polydipsia, and weight loss.  
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• It is caused by partial or total lack of insulin and alteration in carbohydrate, protein and fat 
metabolism that creates defects in insulin-mediated signal pathways, resulting in decreased glucose 
transportation from blood into muscle and fat cells.  
• The major risk is vascular injury leading to heart disease, which is accelerated by increased lipid 
levels and hypertension. Management of diabetes includes: control of blood glucose level and lipids; 
and reduction of hypertension. 
 Fenugreek ( Trigonella foenum-graecum) is a plant in the family Fabaceae. Fenugreek is used both as 
herb (the leaves) and as a spice . Fenugreek has many medicinal and culinary purposes involving the seeds 
and the leaves.  Both Indian Ayurvedic medicine and traditional Chinese medicine recommend fenugreek to 
treat various disorders.   
Fenugreek seeds are a rich source of the polysaccharide galactomannan. They are also a source 
of saponins such as diosgenin, yamogenin, gitogenin, tigogenin, and neotigogens. Other bioactive 
constituents of fenugreek include mucilage, volatile oils, and alkaloids such as choline and trigonelline  
,which has been shown to lower blood sugar and prevent diabetes induced cataract. It also lowers cholesterol 
and triglycerides. 
Fenugreek seed has many amino acids but the most abundant amino acid is 4-hydroxyisoleucine. This amino 
acid has shown to stimulate the pancreas to release insulin (Diabetes 1998). Insulin causes blood sugar to 
drop which may help ease diabetic symptoms. Fenugreek also regulates blood sugar through the enzymes 
sucrase and alpha-amylase. By inhibiting these two enzymes, fenugreek can help slow the break down of 
carbohydrates into sugar further reducing blood sugar levels in the body.  
Fenugreek seeds are 55 percent soluble fiber. This gel-forming fiber absorbs water as it passes through the 
gut and swells up, binding with the food. It delays gastric emptying, slows down carbohydrate absorption and 
inhibits glucose transport. Nearly 50% dry weight of seeds as well as SDF is edible dietary fiber, making it 
the highest concentration among all natural sources of fiber. About 30% of SDF (w/w) is gel-forming 
SOLUBLE fibers similar to guar gum, psyllium husk and oat bran. The INSOLUBLE fiber (20% of SDF), is 
bulk-forming like wheat bran.  
comparision of Fiber content in some major food grains :  
 
COMPOSITION of NATURAL SOURCES of VEGETABLE FIBER 
Source Total Fiber Soluble Fiber Insoluble Fiber Protein Fat 
Fenugreek Seeds 46 - 48% 20 - 28% 18 - 24% 26 - 30% 4 - 8% 
Soya Bean 20% 15 - 18% 3 - 5% 40 - 43% 19% 
Oats 15 - 18% 7 - 8% 7 - 8% 14 - 19% N/A 
Wheat 12% 1 - 3% 9 - 11% 10 - 12% 1 - 3% 
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Guar Bean 40% 25% 15% 28% 10 - 15% 
Psyllium seed 24 - 26% 24 - 25% 1 - 2% 5% Trace 
 
The WHO recommends that any diabetic should include 15-25 gram of beta glucans per day. 1,3 
2. Methodology -   A detailed clinical examination was carried out and recorded. The criteria for the 
selection of patients are as follows: 
• All patients are sedentary middle aged workers. 
• Patients with complications were not included. 
• Patients selected were explained the outline and aim of the study. They were given advice regarding 
the incorporation of fenugreek powder in their daily routine. 
• We made three groups. Group A fed 5gm, group B fed 10 gm and group C fed 15 gm of fenu greek 
seed in the powdered form. 
• Patients are recalled after 2 weeks for the base line investigation Anthropometric data, GTT (75 gm 
oral glucose tolerance test), blood glucose, and serum lipid profile to know the proper effect of 
fenugreek seed. 
Clinical evaluations was done at periodic intervals and were repeated regularly as per to the protocol. The 
test applied for clinical estimation of blood glucose is GOD-POD method.The method of GOD-POD is 
described below: 
GOD POD(Glucose oxidase Peroxidase) method\ 
Principle- The –CHO (aldehyde) group of carbohydrate is oxidized by glucose oxidase to give 
gluconic acid and water. The oxygen reacts with 4- aminophenazone in the presence of phenol to form 
a pink colored compound and intensity of which can be determined at 530 nm.The overall reaction is: 
Glucose+H2O+O2---------------gluconic acid+H2O2 
H2O2- Peroxidase--------------------H2O+O2 
 
Sample- Plasma or serum 
 Reagents- 
1. Buffer or enzymes- this reagent is prepared by mixing following constituent in 100 ml of 
phosphate buffer(N/10) 
a. glucose oxidase-650units 
b. peroxidase-500units 
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c. 4 aminophenazone-20mg 
d. Sodium azide-30mg 
2. Phenol reagent(ready to use)-100mg/dl 
3. glucose standard- 100mg/dl 
Preparation of glucose reagent – mix the two parts of buffer reagent and 1 part of phenol reagent to 
get glucose reagent. It is preferable to prepare the reagent fresh. Otherwise it is stable at 2-8*C in an 
amber colored bottle for 2 weeks. bring the reagent to room temperature before use. 
Procedure- Pipette in tubes labeled as follows; 
 Test Standard Blank 
Glucose reagent(ml) 3.0 3.0 3.0 
Plasma or serum(ml) 0.02   
Glucose standard100mg/dl(ml)  0.02  
Distilled water(ml)   0.02 
Calculation- Plasma or serum glucose (mg/dl) =O.D of test\O.D of standard x 100. 
Note; avoid using contaminated or hemolyzed sample. 
3. Result and Discussion – In this study 108 patients were studied for a period of one month. All these 
patients developed a sense of well being and showed significant fall in their glycolated hemoglobin. In 
these patients there was significant decrease in the body weight and increase in lean body mass. Group A 
fed 5 gm, group B fed 10 gm and group C fed 15 gm of fenugreek seed in the powdered form. 
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 From the study it is clear that small dose of fenugreek seed are not effective significantly. As in group A 
there is no significant difference in fasting and postprandial blood glucose but there is fall in blood glucose 
is seen in group B, whereas in group C there is mild decrease in blood glucose is observe. 
4 Conclusion- This study confirms that the amount of fenugreek seed is inversely proportional to the 
glucose resistance and support the hypothesis that diets with a low glycemic load and high soluble fibres 
reduces the blood glucose level in Diabetic patients.. 
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